Anti-CCP antibodies: the past, the present and the future (Q34190363)

31 July 2017

1 reference

title

Anti-CCP antibodies: the past, the present and the future (English)

1 reference

31 July 2017

1 reference

Walther J van Venrooij

series ordinal

1

1 reference

31 July 2017

Joyce J B C van Beers

series ordinal

2

1 reference

31 July 2017

Ger J M Pruijn

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

7 June 2011

1 reference

Nature Reviews Rheumatology

31 July 2017

published in

1 reference

31 July 2017

volume

7

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

391-398

1 reference

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The use of citrullinated peptides and proteins for the diagnosis of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

A NEW SERUM FACTOR IN PATIENTS WITH RHEUMATOID ARTHRITIS; THE ANTIPERINUCLEAR FACTOR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Expression of epidermal keratins and filaggrin during human fetal skin development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The perinuclear factor, a rheumatoid arthritis-specific autoantigen, is not present in keratohyalin granules of cultured buccal mucosa cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

All you wanted to know about anti-CCP but were afraid to ask

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The presence of citrullinated proteins is not specific for rheumatoid synovial tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated pr

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

HLA-DR1001 presents "altered-self" peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

New classification of the shared epitope in rheumatoid arthritis: impact on the production of various anti-citrullinated protein antibodies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

On the origins of complex immune-mediated disease: the example of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

An important step towards completing the rheumatoid arthritis cycle

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Immunity to citrullinated proteins in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Diagnostic value of anti-human citrullinated fibrinogen ELISA and comparison with four other anti-citrullinated protein assays

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Analytical and diagnostic characteristics of 11 2nd- and 3rd-generation immunoenzymatic methods for the detection of antibodies to citrullinated proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Diagnostic value of antibodies against a modified citrullinated vimentin in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Do all anti-citrullinated protein/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein/peptide antibody tests in patients with and without rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Anti-cyclic citrullinated peptide antibodies are a collection of anti-citrullinated protein antibodies and contain overlapping and non-overlapping reactivities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Marked differences in fine specificity and isotype usage of the anti-citrullinated protein antibody in health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

RETRACTED: Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Citrulline dependence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus as a marker of deforming/erosive arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The anti-cyclic citrullinated peptide response in tuberculosis patients is not citrulline-dependent and sensitive to treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The relationship between the presence of anti-cyclic citrullinated peptide antibodies and clinical phenotype in very early rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: A double-blind, randomized, placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Anticitrullinated protein antibody (ACPA) in rheumatoid arthritis: influence of an interaction between HLA-DRB1 shared epitope and a deletion polymorphism in glutathione S-transferase in a cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Smoking is a major preventable risk factor for rheumatoid arthritis: estimations of risks after various exposures to cigarette smoke

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Effect of dexamethasone on autoantibody levels and arthritis development in patients with arthralgia: a randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Structure and pathogenicity of antibodies specific for citrullinated collagen type II in experimental arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Autoimmunity against fibrinogen mediates inflammatory arthritis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Differences in synovial tissue infiltrates between anti–cyclic citrullinated peptide–positive rheumatoid arthritis and anti–cyclic citrullinated peptide–negative rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll‐like receptor 4 and Fcγ receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Bacterial and human peptidylarginine deiminases: targets for inhibiting the autoimmune response in rheumatoid arthritis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2011.76

The predictive value of anti-cyclic citrullinated peptide antibodies in early arthritis.

31 March 2020

1 reference

12 December 2020

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis

1 reference

12 December 2020

Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides

1 reference

12 December 2020

Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status

1 reference

12 December 2020

The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues

1 reference

12 December 2020

The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors?

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2011.76

1 reference

Dimensions Publication ID

31 July 2017

1051829803

0 references

1 reference